Doskocil Manufacturing Company, Inc.

Arlington, TX ManufacturingNAICS 326100

Self-funded health planPlan year 2025Renews January
598Participants-13% vs. prior year
$1.4MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#131 of 149Manufacturing in TXBy participants

Overview

Doskocil Manufacturing Company, Inc. sponsors a self-funded health plan that covered 598 participants in plan year 2025, down 13% from the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
598 · prior year 690
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Doskocil Manufacturing Company, Inc. Health Insurance Plan, plan 501 (598 participants); Doskocil Manufacturing Company Inc. Employee Injury Benefit Plan, plan 502 (584 participants)
Broker compensation
$133K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityPrepaid legalLong-term disabilityDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Metropolitan Life Insurance CompanyVision, Life, Short-term disability, Long-term disability876$295K$27K
Cigna Health and Life Insurance Company and AffiliatesDental389$274K$19K
MetLife Legal PlansLegal45$12K$2K
Zurich American Insurance CompanyBusiness Travel Accident526$6K$2K
ADPEmployee Assistance Program560——

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$1.4M/ year

Estimated prescription spend: 598 participants × $2,371 national average per member. Usually higher once dependents are counted.

$37K–$91K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$11K–$27K
Lower-cost therapeutic alternatives$16K–$33K
Generic pricing vs. actual cost$7K–$20K
PBM contract terms$4K–$11K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Doskocil Manufacturing Company, Inc.
Sponsor EIN
75-1281683
Plan numbers
501, 502
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 75-1281683 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
Petmate Retirement Plan
Type
401(k) plan
Participants
994

About this data

Source: Doskocil Manufacturing Company, Inc.'s Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Doskocil Manufacturing Company, Inc..

Request a correction · Methodology